Odonate Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Odonate Therapeutics, Inc.‘s stocks are currently a part of 6 hedge funds’ portfolios, which represents 14.26% of the total amount of its stocks outstanding. This makes up a total of 5.40M shares of Odonate Therapeutics, Inc.. Compared to the previous quarter, the number fell by -77.69% or -18.83M shares fewer. As for the holding position changes, 66.67% (4) of current holders sold a part of the shares held, and 633.33% (38) closed the holdings completely.
Hedge funds holding Odonate Therapeutics (Q4 2017 – Q1 2022)
| Q4 2017 | 27 |
|---|---|
| Q1 2018 | 44 |
| Q2 2018 | 50 |
| Q3 2018 | 52 |
| Q4 2018 | 55 |
| Q1 2019 | 56 |
| Q2 2019 | 75 |
| Q3 2019 | 82 |
| Q4 2019 | 87 |
| Q1 2020 | 78 |
| Q2 2020 | 94 |
| Q3 2020 | 86 |
| Q4 2020 | 93 |
| Q1 2021 | 76 |
| Q2 2021 | 63 |
| Q3 2021 | 56 |
| Q4 2021 | 44 |
| Q1 2022 | 6 |
Hedge funds changes in Odonate Therapeutics positions (Q4 2017 – Q1 2022)
| Q4 2017 | 27 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2018 | 25 | 7 | 9 | 8 | -5 |
| Q2 2018 | 8 | 21 | 10 | 2 | 9 |
| Q3 2018 | 6 | 24 | 13 | 4 | 5 |
| Q4 2018 | 9 | 17 | 22 | 6 | 1 |
| Q1 2019 | 7 | 20 | 19 | 6 | 4 |
| Q2 2019 | 20 | 32 | 15 | 0 | 8 |
| Q3 2019 | 17 | 41 | 14 | 9 | 1 |
| Q4 2019 | 13 | 34 | 24 | 8 | 8 |
| Q1 2020 | 5 | 20 | 35 | 12 | 6 |
| Q2 2020 | 18 | 35 | 31 | 2 | 8 |
| Q3 2020 | 23 | 39 | 16 | 31 | -23 |
| Q4 2020 | 22 | 39 | 23 | 15 | -6 |
| Q1 2021 | 22 | 25 | 22 | 39 | -32 |
| Q2 2021 | 11 | 20 | 24 | 24 | -16 |
| Q3 2021 | 7 | 12 | 27 | 14 | -4 |
| Q4 2021 | 9 | 18 | 12 | 21 | -16 |
| Q1 2022 | 0 | 0 | 4 | 38 | -36 |
Hedge funds changes in Odonate Therapeutics stock options (Q4 2017 – Q1 2022)
| Q4 2017 | 0 | 0 |
|---|---|---|
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 1,618,000 |
| Q2 2020 | 466,000 | 1,706,000 |
| Q3 2020 | 3,760,000 | 1,252,000 |
| Q4 2020 | 2,838,000 | 2,112,000 |
| Q1 2021 | 724,000 | 657,000 |
| Q2 2021 | 581,000 | 97,000 |
| Q3 2021 | 68,000 | 99,000 |
| Q4 2021 | 0 | 30,000 |
| Q1 2022 | 0 | 0 |